ID

37354

Descrição

Study ID: 111592 Clinical Study ID: 111592 Study Title: A Randomized, Double-blind, Placebo-controlled, Doseescalation Study to Assess the Anti-inflammatory Activity, Efficacy, and Safety of Intravenous SB-681323 in Subjects at Risk for Development of Acute Lung Injury or ARDS Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00996840 See https://clinicaltrials.gov/ct2/show/NCT00996840 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Placebo, SB-681323 Trade Name: N/A Study Indication: Lung Injury, Acute The primary objective of this phase 2 trial is to evaluate the safety and tolerability of intravenous dilmapimod/SB-681323 given in escalating dosages and over different intervals for three days in trauma patients at risk for the development of ALI or ARDS. This study consists of Screening, infusion of dilmapimod/SB-681323 on days 1-3, examination/sampling up to early day 5 (denoted as "Day 3 - 48 hrs") and a Follow-up on day 7. There are four cohorts, cohorts 1 and 3 receive the medication (or placebo) infusion over 4 hours, cohorts 2 and 4 over 24 hours. This form contains details on the administration of the investigational product and is to be filled in at Day 1, 2 and 3. Additionally, this form also contains Randomisation information and the assignment of the participant to one of the four cohorts for/prior to the first medication administration.

Link

https://clinicaltrials.gov/ct2/show/NCT00996840

Palavras-chave

Versões (2)
  1. 16/07/2019 16/07/2019 -
  2. 20/07/2019 20/07/2019 -
Titular dos direitos

GlaxoSmithKline

Transferido a

20 de julho de 2019

DOI

Para um pedido faça login.

Licença

Creative Commons BY-NC 3.0
Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Voltar para os comentários do modelo
Comentários do grupo de itens para :

Comentários do item para :

  • Os mais recentes
  • Os mais antigos
  • Preferidos
  • Os mais recentes
    • Os mais recentes
    • Os mais antigos
    • Preferidos

Sem comentários

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

SB-681323 in ALI/ARDS risk patients - NCT00996840

Inglês

Investigational Product - IV Dosing, Randomisation, Cohort Assignment

1 Formulários  
Administrative Data
Descrição

Administrative Data

Alias
UMLS CUI-1
C1320722
Subject ID
Descrição

Subject ID

Tipo de dados

integer

Alias
UMLS CUI [1]
C2348585
Date of Visit
Descrição

please fill in the form for each of the three study days

Tipo de dados

integer

Alias
UMLS CUI [1]
C1320303
Which Cohort is the subject enrolled in?
Descrição

Please ensure the Cohort selected is correct before submitting. Medication is infused over 4 or 24 hours depending on the cohort.

Tipo de dados

text

Alias
UMLS CUI [1]
C0599755
Date/Time of Cohort Assignment
Descrição

Date/Time of Cohort Assignment

Tipo de dados

datetime

Alias
UMLS CUI [1,1]
C0599755
UMLS CUI [1,2]
C1516050
UMLS CUI [1,3]
C1264639
First Administration
Descrição

First Administration

Alias
UMLS CUI-1
C3469597
Dosage Duration (per Protocol)
Descrição

Cohorts 1/3: 0-4 hrs Cohorts 2/4: 0-24hrs

Tipo de dados

integer

Alias
UMLS CUI [1,1]
C0449238
UMLS CUI [1,2]
C3469597
UMLS CUI [1,3]
C0304229
Start Date and Time
Descrição

Start Date and Time

Tipo de dados

datetime

Alias
UMLS CUI [1]
C3897500
Stop Date and Time
Descrição

Stop Date and Time

Tipo de dados

datetime

Alias
UMLS CUI [1]
C3899266
Volume administered (mL)
Descrição

Volume administered

Tipo de dados

float

Unidades de medida
  • mL
Alias
UMLS CUI [1]
C2349139
mL
Administration post interruption
Descrição

Administration post interruption

Alias
UMLS CUI-1
C3469597
UMLS CUI-2
C0687676
UMLS CUI-3
C1512900
Dosage Duration (per Protocol)
Descrição

Cohorts 1/3: 0-4 hrs Cohorts 2/4: 0-24 hrs

Tipo de dados

integer

Alias
UMLS CUI [1,1]
C0449238
UMLS CUI [1,2]
C3469597
UMLS CUI [1,3]
C0304229
Start Date and Time
Descrição

Start Date and Time

Tipo de dados

datetime

Alias
UMLS CUI [1]
C3897500
Stop Date and Time
Descrição

Stop Date and Time

Tipo de dados

datetime

Alias
UMLS CUI [1]
C3899266
Volume administered (mL)
Descrição

Volume administered

Tipo de dados

float

Unidades de medida
  • mL
Alias
UMLS CUI [1]
C2349139
mL
Investigational Product Container Number
Descrição

Investigational Product Container Number

Alias
UMLS CUI-1
C0304229
UMLS CUI-2
C0180098
UMLS CUI-3
C0600091
Investigational Product Container Number
Descrição

Record the identifying number from the investigational product container dispensed at this visit

Tipo de dados

text

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0180098
UMLS CUI [1,3]
C0600091
Treatment Confirmation
Descrição

Treatment Confirmation

Alias
UMLS CUI-1
C0750484
UMLS CUI-2
C0087111
Did the subject receive the correct treatment (e.g., treatment which the subject was assigned to) during this dosing interval?
Descrição

If no, record reasons

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C2349182
Reason incorrect treatment
Descrição

if applicable

Tipo de dados

text

Alias
UMLS CUI [1,1]
C0566251
UMLS CUI [1,2]
C0087111
UMLS CUI [1,3]
C3827420
Randomisation Number
Descrição

Randomisation Number

Alias
UMLS CUI-1
C0034656
UMLS CUI-2
C0237753
Was the subject able to be randomised?
Descrição

If yes, provide Randomisation Number and Date/time of randomisation

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0034656
UMLS CUI [1,2]
C0332149
Randomisation Number
Descrição

if applicable

Tipo de dados

integer

Alias
UMLS CUI [1,1]
C0034656
UMLS CUI [1,2]
C0237753
Date/time of randomisation
Descrição

if applicable

Tipo de dados

datetime

Alias
UMLS CUI [1,1]
C0034656
UMLS CUI [1,2]
C1264639
Voltar ao início da página

Similar models

Investigational Product - IV Dosing, Randomisation, Cohort Assignment

1 Formulários
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
Administrative Data
C1320722 (UMLS CUI-1)
Subject ID
Item
Subject ID
integer
C2348585 (UMLS CUI [1])
Item
Date of Visit
integer
C1320303 (UMLS CUI [1])
Date of Visit
Code List
Date of Visit
CL Item
Day 1 (1)
CL Item
Day 2 (2)
CL Item
Day 3 (3)
Item
Which Cohort is the subject enrolled in?
text
C0599755 (UMLS CUI [1])
Cohort
Code List
Which Cohort is the subject enrolled in?
CL Item
Cohort 1 (3mg/Placebo IV / 4hrs) (C1)
CL Item
Cohort 2 (7.5mg/Placebo IV / 24hrs) (C2)
CL Item
Cohort 3 (7.5mg/Placebo IV / 4hrs) (C3)
CL Item
Cohort 4 (10mg/Placebo IV / 24hrs) (C4)
Date/Time of Cohort Assignment
Item
Date/Time of Cohort Assignment
datetime
C0599755 (UMLS CUI [1,1])
C1516050 (UMLS CUI [1,2])
C1264639 (UMLS CUI [1,3])
Item Group
First Administration
C3469597 (UMLS CUI-1)
Item
Dosage Duration (per Protocol)
integer
C0449238 (UMLS CUI [1,1])
C3469597 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,3])
Dosage Duration
Code List
Dosage Duration (per Protocol)
CL Item
0-4 hrs (1)
CL Item
0-24 hrs (2)
Start Date and Time
Item
Start Date and Time
datetime
C3897500 (UMLS CUI [1])
Stop Date and Time
Item
Stop Date and Time
datetime
C3899266 (UMLS CUI [1])
Volume administered
Item
Volume administered (mL)
float
C2349139 (UMLS CUI [1])
Item Group
Administration post interruption
C3469597 (UMLS CUI-1)
C0687676 (UMLS CUI-2)
C1512900 (UMLS CUI-3)
Item
Dosage Duration (per Protocol)
integer
C0449238 (UMLS CUI [1,1])
C3469597 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,3])
Dosage Duration
Code List
Dosage Duration (per Protocol)
CL Item
0-4 hrs (1)
CL Item
0-24 hrs (2)
Start Date and Time
Item
Start Date and Time
datetime
C3897500 (UMLS CUI [1])
Stop Date and Time
Item
Stop Date and Time
datetime
C3899266 (UMLS CUI [1])
Volume administered
Item
Volume administered (mL)
float
C2349139 (UMLS CUI [1])
Item Group
Investigational Product Container Number
C0304229 (UMLS CUI-1)
C0180098 (UMLS CUI-2)
C0600091 (UMLS CUI-3)
Investigational Product Container Number
Item
Investigational Product Container Number
text
C0304229 (UMLS CUI [1,1])
C0180098 (UMLS CUI [1,2])
C0600091 (UMLS CUI [1,3])
Item Group
Treatment Confirmation
C0750484 (UMLS CUI-1)
C0087111 (UMLS CUI-2)
Correct treatment received
Item
Did the subject receive the correct treatment (e.g., treatment which the subject was assigned to) during this dosing interval?
boolean
C0087111 (UMLS CUI [1,1])
C2349182 (UMLS CUI [1,2])
Reason incorrect treatment
Item
Reason incorrect treatment
text
C0566251 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C3827420 (UMLS CUI [1,3])
Item Group
Randomisation Number
C0034656 (UMLS CUI-1)
C0237753 (UMLS CUI-2)
Randomisation possible
Item
Was the subject able to be randomised?
boolean
C0034656 (UMLS CUI [1,1])
C0332149 (UMLS CUI [1,2])
Randomisation Number
Item
Randomisation Number
integer
C0034656 (UMLS CUI [1,1])
C0237753 (UMLS CUI [1,2])
Randomisation Date/Time
Item
Date/time of randomisation
datetime
C0034656 (UMLS CUI [1,1])
C1264639 (UMLS CUI [1,2])
Voltar ao início da página 

Ajuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial